Clinical trials drive medical advances and have a direct impact on health outcomes. Thoughtful, transparent systems for the responsible sharing of clinical trial data are important in maximizing the contribution of the patients who put themselves at risk by participating in clinical trials. The New England Journal of Medicine (NEJM) is committed to working with the global medical community to make the sharing of clinical trial data an effective, efficient and sustainable part of biomedical research.
To initiate an open conversation among researchers, data analysts, and patient participants, NEJM is hosting a web event, Aligning Incentives for Sharing Clinical Trial Data summit, on April 3-4, 2017. Leading up to the event, NEJM is sponsoring a SPRINT Data Analysis Challenge to demonstrate how clinical trial data can be used to identify additional advances in human health.
Are you up to the SPRINT Challenge to explore the potential from sharing clinical trial data? If so, NEJM challenges you to analyse the dataset underlying the SPRINT article — A Randomized Trial of Intensive versus Standard Blood-Pressure Control (N Engl J Med 373: 2103-2116) — and identify a novel scientific or clinical finding to advance medical science.